Identification and In Vitro Evaluation of Milkfish (

Anastacio T Cagabhion, Wen-Ling Ko, Ting-Jui Chuang, Rotimi E Aluko, Yu-Wei Chang

Abstract read

In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anastacio T CagabhionDepartment of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID 0000-0002-9642-9383

Wen-Ling KoDepartment of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan.

Ting-Jui ChuangDepartment of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan.

Rotimi E AlukoDepartment of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, MB R3T2N2, Canada.ORCID 0000-0002-9025-2513

Yu-Wei ChangDepartment of Food Science, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID 0000-0003-4370-2988

Funding

National Science and Technology Council NSTC: 111-2320-B-019-003-MY3

6 · The paper itself

Abstract

The study presents the potential of milkfish frame, a by-product of milkfish processing, as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory and antioxidant peptides with potential applications in type 2 diabetes management. Proteomic analysis identified key proteins, including 65 kDa warm temperature acclimation protein 1 and myosin heavy chain. In silico prediction (BIOPEP-UWM) guided the selection of proteases for generating DPP-IV inhibitory peptides. Enzymatic hydrolysates were produced and evaluated for bioactivity. Among the treatments, pepsin hydrolysis (2%

Indexed as

antioxidantbioactivityDPP-IV inhibitoryenzymatic hydrolysismilkfish by-productstype 2 diabetes

Identifiers

PMID41153992

DOI10.3390/foods14203456

PMCPMC12562398

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.